0.10
+0.004(+4.06%)
Currency In USD
| Previous Close | 0.1 |
| Open | 0.13 |
| Day High | 0.13 |
| Day Low | 0.09 |
| 52-Week High | 5.5 |
| 52-Week Low | 0.07 |
| Volume | 150.98M |
| Average Volume | 28.75M |
| Market Cap | 4.28M |
| PE | -0.14 |
| EPS | -0.71 |
| Moving Average 50 Days | 0.14 |
| Moving Average 200 Days | 0.37 |
| Change | 0 |
If you invested $1000 in Profusa, Inc. Common Stock (PFSA) since IPO date, it would be worth $50.74 as of January 19, 2026 at a share price of $0.103. Whereas If you bought $1000 worth of Profusa, Inc. Common Stock (PFSA) shares 6 months ago, it would be worth $112.64 as of January 19, 2026 at a share price of $0.103.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
GlobeNewswire Inc.
Jan 16, 2026 12:30 PM GMT
Research-use-only offerings are commercially available, enabling immediate product and service revenue generation Targets the global CRO market of $47.9 billion in 2025 and growing at 7% CAGR BERKELEY, Calif, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Profu
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
GlobeNewswire Inc.
Jan 08, 2026 12:30 PM GMT
Dr. Theodosios Bisdas is a renowned vascular surgeon and Head of Clinic of Vascular Surgery at the Athens Medical Center BERKELEY, Calif, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial sta
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
GlobeNewswire Inc.
Dec 31, 2025 12:30 PM GMT
MedSell commercializes Lumee™ Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now reach approximately 200,000 annual CLI cases in th